EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Super-enhancer-driven ZFP36L1 promotes PD-L1 expression in infiltrative gastric cancer

Xujin Wei iD, Jie Liu iD, Jia Cheng iD, Wangyu Cai, Wen Xie, Kang Wang, Lingyun Lin, Jingjing Hou, Jianchun Cai iD, Huiqin Zhuo iD

eLife · 07.10.2024 · 13

DOI: 10.7554/elife.96445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 07.10.2024. Verfasst von Xujin Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopic Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, B7-H1 Antigen, Butyrate Response Factor 1, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) is a major cause of cancer-related mortality worldwide. Despite the widespread recognition of tumor immunotherapy in treating unresectable GC, challenges, including ineffective immunotherapy and drug resistance, persist. Therefore, understanding the regulatory mechanisms of PD-L1, particularly in the context of super-enhancers (SEs) and zinc finger protein 36 ring finger protein-like 1 (ZFP36L1) RNA-binding protein, is crucial. In this study, we performed H3K27ac Cleavage Under Targets and Tagmentation (CUT&Tag) sequencing, investigated the heterogeneity of SEs between two GC subtypes with differential growth patterns, and revealed the immune escape signatures driven by ZFP36L1-SE in infiltrative GC through SEs inhibitors treatment. The regulation of ZFP36L1 to PD-L1 was evaluated by quantitative PCR, western blot, flow cytometry, and immunohistochemistry. Furthermore, we explored its regulatory mechanisms using a combination of molecular biology techniques, including luciferase reporter assay, GST/RNA pull-down, chromatin immunoprecipitation (ChIP)/RIP experiments, and in vivo functional assays. We demonstrated that ZFP36L1, driven by an SE, enhances IFN-γ-induced PD-L1 expression, with SPI1 identified as the specific transcription factor binding to ZFP36L1-SE. Mechanistically, ZFP36L1 binds to the adenylate uridylate-rich element in the 3ʹ untranslated region (3ʹUTR) of HDAC3 mRNA, exacerbating its mRNA decay, and thereby facilitating PD-L1 abnormal transcriptional activation. Collectively, our findings provide mechanistic insights into the role of the SPI1-ZFP36L1-HDAC3-PD-L1 signaling axis in orchestrating immune escape mechanisms in GC, thereby offering valuable insights into the potential targets for immune checkpoint therapy in GC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsB7-H1 AntigenButyrate Response Factor 1Gene Expression Regulation, NeoplasticHumansCell Line, TumorMiceAnimalsEnhancer Elements, Genetic

Stichwörter der Autor:innen

PD-L1cancer biologyhumanmRNA decaystomach neoplasmsuper-enhancer

Substanzen

B7-H1 AntigenCD274 protein, humanZFP36L1 protein, humanButyrate Response Factor 1

Autor:innen und Institutionen

  • Endoscopic Center, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • The Graduate School of Fujian Medical University, Fuzhou, China.
  • Department of Gastrointestinal Surgery, Zhongshan Hospital of Xiamen University, Institute of Gastrointestinal Oncology, School of Medicine, Xiamen University, Xiamen, China.
  • Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, China.

ORCID-Profile: Xujin Wei, Jie Liu, Jia Cheng, Jianchun Cai, Huiqin Zhuo

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Wei, X., Liu, J., Cheng, J., Cai, W., Xie, W., Wang, K., Lin, L., Hou, J., Cai, J., & Zhuo, H. (2024). Super-enhancer-driven ZFP36L1 promotes PD-L1 expression in infiltrative gastric cancer. eLife, 13. https://doi.org/10.7554/elife.96445

Vancouver

Wei X, Liu J, Cheng J, Cai W, Xie W, Wang K, et al. Super-enhancer-driven ZFP36L1 promotes PD-L1 expression in infiltrative gastric cancer. eLife. 2024;13. doi:10.7554/elife.96445

BibTeX
@article{Wei2024,
  author = {Wei, Xujin and Liu, Jie and Cheng, Jia and Cai, Wangyu and Xie, Wen and Wang, Kang and Lin, Lingyun and Hou, Jingjing and Cai, Jianchun and Zhuo, Huiqin},
  title = {Super-enhancer-driven ZFP36L1 promotes PD-L1 expression in infiltrative gastric cancer},
  journal = {eLife},
  year = {2024},
  volume = {13},
  doi = {10.7554/elife.96445}
}
Kostenlos starten →